CAS 96020-91-6|Eflornithine (hydrochloride, hydrate)

Introduction:Basic information about CAS 96020-91-6|Eflornithine (hydrochloride, hydrate), including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Common NameEflornithine (hydrochloride, hydrate)
CAS Number96020-91-6Molecular Weight236.64500
Density1.293g/cm3Boiling Point347ºC at 760mmHg
Molecular FormulaC6H15ClF2N2O3Melting Point>210ºC (dec.)
MSDS/Flash Point163.7ºC

Names

NameDL-α-Difluoromethylornithine Hydrochloride Monohydrate
SynonymMore Synonyms

Eflornithine (hydrochloride, hydrate) BiologicalActivity

DescriptionEflornithine hydrochloride, hydrate is a specific, irreversible inhibitor of the enzyme ornithine decarboxylase. Eflornithine is a medication for the treatment of African trypanosomiasis and excessive facial hair growth in women.
Related CatalogSignaling Pathways >>Others >>OthersResearch Areas >>Others
In VivoEflornithine is the only new molecule registered for the treatment of human African trypanosomiasis over the last 50 years. It is the drug used mainly as a back-up for melarsoprol refractory Trypanosoma brucei gambiense cases[1]. In subjects with excessive, unwanted facial hair, eflornithine 15% cream is superior to placebo in reducing hair growth. After 24 weeks' treatment, 58% of eflornithine and 34% of placebo subjects have at least some improvement in facial hirsutism[2]. The hair growth inhibitory activity of eflornithine is significantly enhanced when the eflornithine cream is applied onto a mouse skin area pretreated with microneedles[3]. Treatment of coarctation hypertensive rats with eflornithine results in a normalization of the contractile intensity to KCI and norepinephrine and relaxations to acetylcholine by 14 days of hypertension[4].
Animal AdminMice: The skin area where the hair is removed is then treated with the eflornithine hydrochloride 13.9% cream (-50 mg per mouse per treatment) using a spatula 2 times a day in an interval of at least 8 h for a maximum period of 36 days[3].
References

[1]. Burri C, et al. Eflornithine for the treatment of human African trypanosomiasis. Parasitol Res. 2003 Jun;90 Supp 1:S49-52.

[2]. Balfour JA, et al. Topical eflornithine. Am J Clin Dermatol. 2001;2(3):197-201; discussion 202.

[3]. Kumar A, et al. A method to improve the efficacy of topical eflornithine hydrochloride cream. Drug Deliv. 2016 Jun;23(5):1495-501.

[4]. Lipke DW, et al. Eflornithine alters changes in vascular responsiveness associated with coarctation hypertension. Clin Exp Hypertens. 1997 Apr;19(3):297-312.

Chemical & Physical Properties

Density1.293g/cm3
Boiling Point347ºC at 760mmHg
Melting Point>210ºC (dec.)
Molecular FormulaC6H15ClF2N2O3
Molecular Weight236.64500
Flash Point163.7ºC
Exact Mass236.07400
PSA98.57000
LogP1.91080
InChIKeyFJPAMFNRCFEGSD-UHFFFAOYSA-N
SMILESCl.NCCCC(N)(C(=O)O)C(F)F.O
Storage condition2~8°C

Safety Information

HS Code2922499990

Customs

HS Code2922499990
SummaryHS:2922499990 other amino-acids, other than those containing more than one kind of oxygen function, and their esters; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) MFN tariff:6.5% General tariff:30.0%

Synonyms

2,5-diamino-2-(difluoromethyl)pentanoic acid,hydrate,hydrochloride
Eflornithine (hydrochloride, hydrate)
CAS 115575-11-6|Liarozole
CAS 902580-50-1|3-(4-chlorophenyl)-N-(3-isopropoxypropyl)-[1,2,3]triazolo[1,5-a]quinazolin-5-amine
Recommended......
TOP